MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/0300060520979151

Медицинская библиотека · The Journal of international medical research · 2020

Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.

Zhong Yanjun, Zhao Lishu, Wu Guobao, Hu Chunhong, Wu Chenfang, Xu Min, Dong Haiyun, Zhang Quan, Wang Guyi, Yu Bo, Lv Jianlei, Wu Chao, Zhang Siye, Cao Chenghui, Shu Long, Pan Yue, Liu Xianling, Wu Fang

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

Association of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) use with coronavirus disease 2019 (COVID-19) remains controversial. We aimed to investigate the impact of ACEI/ARB use on all-cause mortality in severe COVID-19 patients with hypertension.

METHODS

We enrolled 650 COVID-19 patients from Changsha and Wuhan city between 17 January 2020 and 8 March 2020. Demographic, clinical characteristics, and outcomes were collected. Multivariable analysis and propensity-score matching were performed to assess the impact of ACEI/ARB therapy on mortality.

RESULTS

Among the 650 patients, 126 who had severe COVID-19 concomitant with hypertension were analyzed. The average age was 66 years and 56 (44.4%) were men. There were 37 ACEI/ARB users and 21 in-hospital deaths (mortality rate, 16.7%). Male sex (odds ratio [OR], 5.13; 95% confidence interval [CI], 1.75 to 17.8), but not ACEI/ARB use (OR, 1.09; 95%CI, 0.31 to 3.43), was an independent risk factor for mortality in severe COVID-19 patients with hypertension. After propensity-score matching, 60 severe COVID-19 patients were included and no significant correlation between use of ACEI/ARB and mortality was observed.

CONCLUSIONS

There was no significant association of ACEI/ARB use with mortality in severe COVID-19 patients with hypertension. These findings support the continuation of ACEI/ARB therapy for such patients.

Для цитирования: Zhong Yanjun, Zhao Lishu, Wu Guobao, Hu Chunhong, Wu Chenfang, Xu Min, Dong Haiyun, Zhang Quan, Wang Guyi, Yu Bo, Lv Jianlei, Wu Chao, Zhang Siye, Cao Chenghui, Shu Long, Pan Yue, Liu Xianling, Wu Fang. Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.. The Journal of international medical research. 2020. DOI: 10.1177/0300060520979151.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.